ABT-869 from BIOVISION, INC.

BIOVISION, INC.

BIOVISION, INC.

155 S. Milpitas Boulevard

Milpitas CA 95035

Phone: 408-493-1800

Phone: 800-891-9699

Fax: 408-493-1801

Email: support@biovision.com

Website: http://www.biovision.com

ABT-869 from BIOVISION, INC.

Name	ABT-869
Description	ABT-869 is multi-targeted inhibitor of all members of the VEGF and PDGF receptor families (e.g., KDR, IC50 value of 4 nM), but has much less activity (IC50 values >1 µM) against unrelated receptor tyrosine kinases, soluble tyrosine kinases or serine/threonine kinases. The kinase inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (IC50 values of 2, 4 and 7 nM for PDGFRbeta, KDR and CSF-1R, respectively) and VEGF-stimulated proliferation (0.2 nM IC50 for human endothelial cells).
Size	5 mg
Applications	n/a
Catalog #	1615-5
Price	$895
Other Names	Linifanib
Supplier Data Page	ABT-869 from BIOVISION, INC.

Information on this site comes from many sources, and Linscott's Directory disclaims responsibility for its accuracy. Pricing is supplier's approximate list price, and actual prices may vary.